These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23951216)

  • 41. Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease.
    Frohlich J; Dobiásová M; Adler L; Francis M
    Physiol Res; 2004; 53(5):481-6. PubMed ID: 15479125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma Lipoprotein(a) Concentration Is Associated With the Coronary Severity but Not With Events in Stable Coronary Artery Disease Patients: A Chinese Cohort Study.
    Zhou BY; Sun D; Wang C; Wu NQ; Guo YL; Zhu CG; Gao Y; Liu G; Dong Q; Li JJ
    Heart Lung Circ; 2019 Jul; 28(7):1009-1017. PubMed ID: 31178022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.
    Vongpromek R; Bos S; Ten Kate GJ; Yahya R; Verhoeven AJ; de Feyter PJ; Kronenberg F; Roeters van Lennep JE; Sijbrands EJ; Mulder MT
    J Intern Med; 2015 Aug; 278(2):166-73. PubMed ID: 25487646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Elevated Lipoprotein(a) Cncentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease].
    Afanasieva OI; Utkina EA; Artemieva NV; Ezhov MV; Adamova IY; Pokrovsky SN
    Kardiologiia; 2016 Jun; 56(6):5-11. PubMed ID: 28290840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipoprotein (a) and the Risk of Chronic Kidney Disease in Hospitalized Japanese Patients.
    Tada H; Yamagami K; Nishikawa T; Yoshida T; Teramoto R; Sakata K; Takamura M; Kawashiri MA
    Intern Med; 2020; 59(14):1705-1710. PubMed ID: 32669515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipoprotein(a) Is Associated with the Presence and Severity of New-Onset Coronary Artery Disease in Postmenopausal Women.
    Yan XN; Jin JL; Hong LF; Guo YL; Wu NQ; Zhu CG; Dong Q; Li JJ
    J Womens Health (Larchmt); 2020 Apr; 29(4):503-510. PubMed ID: 31905317
    [No Abstract]   [Full Text] [Related]  

  • 48. Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study.
    Liu SL; Wu NQ; Guo YL; Zhu CG; Gao Y; Sun J; Xu RX; Liu G; Dong Q; Li JJ
    Postgrad Med J; 2019 Oct; 95(1128):534-540. PubMed ID: 31315919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein(a) and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease.
    Amemiya H; Arinami T; Kikuchi S; Yamakawa-Kobayashi K; Li L; Fujiwara H; Hiroe M; Marumo F; Hamaguchi H
    Atherosclerosis; 1996 Jun; 123(1-2):181-91. PubMed ID: 8782849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patients.
    Shi YP; Cao YX; Jin JL; Liu HH; Zhang HW; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Coron Artery Dis; 2021 Jan; 32(1):78-83. PubMed ID: 32804783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men.
    El-Saed A; Sekikawa A; Zaky RW; Kadowaki T; Takamiya T; Okamura T; Edmundowicz D; Kita Y; Kuller LH; Ueshima H
    J Epidemiol; 2007 Nov; 17(6):179-85. PubMed ID: 18094516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic analysis of emerging risk factors in coronary artery disease.
    van Iperen EP; Sivapalaratnam S; Holmes MV; Hovingh GK; Zwinderman AH; Asselbergs FW
    Atherosclerosis; 2016 Nov; 254():35-41. PubMed ID: 27684604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of coronary artery calcification with MDA-LDL-C/LDL-C and urinary 8-isoprostane in Japanese patients with type 2 diabetes.
    Ono M; Takebe N; Oda T; Nakagawa R; Matsui M; Sasai T; Nagasawa K; Honma H; Kajiwara T; Taneichi H; Takahashi Y; Takahashi K; Satoh J
    Intern Med; 2014; 53(5):391-6. PubMed ID: 24583425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The predictive power of low-density lipoprotein cholesterol for coronary calcification.
    Allison MA; Wright M; Tiefenbrun J
    Int J Cardiol; 2003 Aug; 90(2-3):281-9. PubMed ID: 12957763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome: a yokohama-acs substudy.
    Matsushita K; Hibi K; Komura N; Kimura Y; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Kosuge M; Ebina T; Tamura K; Kimura K
    J Cardiol; 2020 Jul; 76(1):66-72. PubMed ID: 32037254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary artery calcification across ethnic groups in Singapore.
    Chia PL; Earnest A; Lee R; Lim J; Wong CP; Chia YW; Weng JY; Negi A; Khatri P; Foo D
    Ann Acad Med Singap; 2013 Sep; 42(9):432-6. PubMed ID: 24162317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atherosclerosis.
    Peltier M; Iannetta Peltier MC; Sarano ME; Lesbre JP; Colas JL; Tribouilloy CM
    Chest; 2002 May; 121(5):1589-94. PubMed ID: 12006448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study.
    Bandara EM; Ekanayake S; Wanigatunge CA; Kapuruge A
    BMC Cardiovasc Disord; 2016 Nov; 16(1):213. PubMed ID: 27825299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.